Despite market volatility and anemic economic data, the Dow Jones Industrial Average, S&P 500 and NASDAQ improved 1.0%, 1.3% and 0.2% in July, respectively. US equity markets came under pressure due to weak retail and employment figures, as well as mixed earnings reports. Slowing economic data from Japan and China, along with rising Spanish and […]
Moscone Convention Center in San Francisco, California, hosted the Semicon West semiconductor and electronics tradeshow from July 10 to 12. As it has in the past few years, the conference was held in conjunction with the Intersolar solar energy show, held at Moscone West over the same days. Preliminary totals from the organizing body, the […]
In June, BD Biosciences, which holds the largest share in the flow cytometry market, released the BD FACSJazz Cell Sorting System, an entry-level flow cytometer. A stream-in-air cell sorter, the FACSJazz utilizes the same Accudrop technology for determining drop delay as BD’s more advanced cell-sorting systems, the FACSAria and Influx, but occupies just 20 x […]
At its press conference announcing its purchase of Navigenics (see page 2), Life Technologies provided details of its plan to grow its diagnostics business. Ronnie Andrews, president of Medical Sciences, cited the company’s qPCR, FISH probes and antibody products as among the product lines that will contribute to its diagnostic offerings. As an example of […]
Held July 15–19 in Los Angeles, California, the annual American Association for Clinical Chemistry (AACC) conference hosted tens of thousands of attendees. The conference presentations and exhibits encompassed both traditional clinical chemistry technologies, such as clinical analyzers, as well as molecular diagnostics techniques, including DNA sequencing and PCR. The conference was held at an interesting […]
In January, when IBO issued its industry forecast for 2012 (see IBO 1/15/12), the industry had just finished two consecutive years of robust growth, which suggested it might be possible for such strong growth to continue. Although at the time we developed the forecast, we did not have the benefit of fourth quarter results for […]
Safety is increasingly on the radar of laboratories. An October 2011 Chemical Safety and Hazard Investigation Board report recommended new hazard evaluation guides and safety bulletins for labs. A company whose products are dedicated to the safe handling of hazardous liquids is SCAT Europe. Based in Mörfelden, Germany, SCAT Europe was founded in 2003 to […]
With the updated financials from Oxford Instruments, HORIBA and Shimadzu, the IBO Laboratory Sales Index has been slightly revised from the numbers that appeared in IBO’s May 15 issue. First-quarter Index sales grew 1.9% organically to $5,752 million. Operating profit climbed 8.6% to $1,253 million, and operating margin was 18.5% of sales. For the fiscal […]
This month, the NSF released preliminary R&D spending numbers for the US federal government for fiscal year 2011 (FY11), ending September 30, 2011. The data suggest the substantial impact that the absence of American Recovery and Reinvestment Act of 2009 (ARRA) funding had on R&D spending in FY11 (see IBO 6/15/12) and general changes in […]
Higher investments in new product development and increased R&D personnel spending elevated R&D spending in 2011. Total R&D spending in US dollars for 18 major publicly held analytical and life science instrument and lab product companies grew 14.2% to $1.96 billion, compared with 12.1% growth for the same companies in 2010 (see table, page 6). […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
